B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

P2RY4

MOLECULAR TARGET

pyrimidinergic receptor P2Y4

UniProt: P51582NCBI Gene: 50305 compounds

P2RY4 (pyrimidinergic receptor P2Y4) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting P2RY4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Uridine Triphosphate Uridine 5'-(tetrahydrogen triphosphate).2.9418
2Adenosine Triphosphate2.087
3Adenosine Monophosphate Adenine nucleotide containing0.691
4Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate).0.691
5Inosine Triphosphate Inosine 5'-(tetrahydrogen triphosphate).0.691

About P2RY4 as a Drug Target

P2RY4 (pyrimidinergic receptor P2Y4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented P2RY4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

P2RY4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.